Table 5.
Antibiotic resistance pattern to Acinetobacter baumannii isolates.
| Antibiotics | Patients (#20) no (%) | Nosocomial (#6) no. (%) | Total resistant (#26) no. (%) | ||
|---|---|---|---|---|---|
| R | S | R | S | ||
| AMP | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| AMC | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| CFX | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| CXM | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| FOX | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| CFM | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| CAZ | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| CRO | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| IPM | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| MEM | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| AMK | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| GEN | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| CIP | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| FOS | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| NIT | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| PIP | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| ATM | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| STR | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| TET | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| CLI | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| CPD | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| ERY | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| SXT | 10 (50) | 10 (50) | 4 (66.6) | 2 (33.3) | 14 (53.8) |
| TZP | 18 (90) | 2 (10) | 5 (83.3) | 1 (16.6) | 23 (88.4) |
| FEP | 16 (80) | 4 (20) | 4 (66.6) | 2 (33.3) | 20 (76.9) |
| NET | 16 (80) | 4 (20) | 4 (66.6) | 2 (33.3) | 20 (76.9) |
| TOB | 18 (90) | 2 (10) | 5 (83.3) | 1 (16.6) | 23 (88.4) |
| LVX | 12 (60) | 8 (40) | 3 (50) | 3 (50) | 15 (57.6) |
| TGC | 0 (0) | 20 (100) | 0 (0) | 6 (100) | (0) |
| CST | 8 (40) | 12 (60) | 2 (33.3) | 4 (66.6) | 10 (38.4) |
| DOX | 15 (75) | 5 (25) | 5 (83.3) | 1 (16.6) | 20 (76.9) |
| NOR | 15 (75) | 5 (25) | 4 (66.6) | 2 (33.3) | 19 (73) |
| CLR | 14 (70) | 6 (30) | 5 (83.3) | 1 (16.6) | 19 (73) |
| MDR | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
| XDR | 20 (100) | 0 (0) | 6 (100) | 0 (0) | 26 (100) |
AMP: ampicillin, AMC: amoxicillin/clavulanate, CFX: cefuroxime, CXM: cefuroxime axetil, FOX: cefoxitin, CFM: cefixime, CAZ: ceftazidime, CRO: ceftriaxone, IPM: imipenem, MEM: meropenem, AMK: amikacin, GEN: gentamicin, CIP: ciprofloxacin, FOS: fosfomycin, NIT: nitrofurantoin, SXT: trimethoprim-sulfamethoxazole, PIP: piperacillin, TZP: piperacillin-tazobactam, FEP: cefepime, ATM: aztreonam, NET: netilmicin, TOB: tobramycin, LVX: levofloxacin, STR: streptomycin, TET: tetracycline, TGC: tigecycline, CST: colistin, CLI: clindamycin, CPD: cefpod-oxime, DOX: doxycycline, NOR: norfloxacin, CLR: clarithromycin, ERY: erythromycin. MDR: multidrug-resistant, XDR: extensively drug resistance, S: suspectable, R: resistant.